Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pericyazine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pericyazine 2.5mg tablets
0402010P0AAADAD
|
Pericyazine | Pericyazine | Central Nervous System | 5,344 |
|
Pericyazine 10mg tablets
0402010P0AAAEAE
|
Pericyazine | Pericyazine | Central Nervous System | 2,481 |
|
Pericyazine 10mg/5ml oral solution
0402010P0AAACAC
|
Pericyazine | Pericyazine | Central Nervous System | 64 |
|
Neulactil 10mg tablets
0402010P0BBABAE
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Neulactil 2.5mg tablets
0402010P0BBAAAD
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Neulactil Forte syrup
0402010P0BBADAC
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Pericyazine 2.5mg/5ml oral liquid
0402010P0AAAGAG
|
Pericyazine | Pericyazine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.